AAAAAA
Results: 1-25/52
Authors:
Eastell, R
Reid, DM
Compston, J
Cooper, C
Fogelman, I
Francis, RM
Hay, SM
Hosking, DJ
Purdie, DW
Ralston, SH
Reeve, J
Russell, RGG
Stevenson, JC
Citation: R. Eastell et al., Secondary prevention of osteoporosis: when should a non-vertebral fracturebe a trigger for action?, QJM-MON J A, 94(11), 2001, pp. 575-597
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, Detection of bone metastases in cancer-patients by F-18-fluoride and F-18-fluorodeoxyglucose positron emission tomography, Q J NUCL M, 45(1), 2001, pp. 47-52
Authors:
Blake, GM
Fogelman, I
Citation: Gm. Blake et I. Fogelman, Peripheral or central densitometry: Does it matter which technique we use?, J CLIN DENS, 4(2), 2001, pp. 83-96
Authors:
Knapp, KM
Blake, GM
Spector, TD
Fogelman, I
Citation: Km. Knapp et al., Multisite quantitative ultrasound: Precision, age- and menopause-related changes, fracture discrimination, and T-score equivalence with dual-energy X-ray absorptiometry, OSTEOPOR IN, 12(6), 2001, pp. 456-464
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Does the combination of quantitative ultrasound and dual-energy X-ray absorptiometry improve fracture discrimination?, OSTEOPOR IN, 12(6), 2001, pp. 471-477
Authors:
Rymer, J
Robinson, J
Fogelman, I
Citation: J. Rymer et al., Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss, OSTEOPOR IN, 12(6), 2001, pp. 478-483
Authors:
Patel, R
Collins, D
Bullock, S
Swaminathan, R
Blake, GM
Fogelman, I
Citation: R. Patel et al., The effect of season and vitamin D supplementation on bone mineral densityin healthy women: A double-masked crossover study, OSTEOPOR IN, 12(4), 2001, pp. 319-325
Authors:
Rea, JA
Chen, MB
Li, J
Marsh, E
Fan, B
Blake, GM
Steiger, P
Smith, IG
Genant, HK
Fogelman, I
Citation: Ja. Rea et al., Vertebral morphometry: A comparison of long-term precision of morphometricX-ray absorptiometry and morphometric radiography in normal and osteoporotic subjects, OSTEOPOR IN, 12(2), 2001, pp. 158-166
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis, J BONE MIN, 16(2), 2001, pp. 406-416
Authors:
Hain, SF
Curran, KM
Beggs, AD
Fogelman, I
O'Doherty, MJ
Maisey, MN
Citation: Sf. Hain et al., FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy, EUR J NUCL, 28(9), 2001, pp. 1336-1340
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Changes in QUS and BMD measurements with antiresorptive therapy: A two-year longitudinal study, CALCIF TIS, 69(3), 2001, pp. 138-146
Authors:
Park-Holohan, SJ
Blake, GM
Fogelman, I
Citation: Sj. Park-holohan et al., Quantitative studies of bone using F-18-fluoride and Tc-99m-methylene diphosphonate: evaluation of renal and whole-blood kinetics, NUCL MED C, 22(9), 2001, pp. 1037-1044
Authors:
McClung, MR
Geusens, P
Miller, PD
Zippel, H
Bensen, WG
Roux, C
Adami, S
Fogelman, I
Diamond, T
Eastell, R
Meunier, PJ
Reginster, JY
Wasnich, RD
Greenwald, M
Kaufman, J
Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340
Authors:
Rea, JA
Blake, GM
Fogelman, I
Citation: Ja. Rea et al., Development of a phantom for morphometric X-ray absorptiometry, BR J RADIOL, 74(880), 2001, pp. 341-350
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, The role of nuclear medicine in monitoring treatment in skeletal malignancy, SEM NUC MED, 31(3), 2001, pp. 206-211
Authors:
Blake, GM
Fogelman, I
Citation: Gm. Blake et I. Fogelman, Monitoring treatment for osteoporosis by using bone densitometry, SEM NUC MED, 31(3), 2001, pp. 212-222
Authors:
Fogelman, I
Blake, GM
Citation: I. Fogelman et Gm. Blake, Untitled, SEM NUC MED, 31(1), 2001, pp. 2-2
Authors:
Blake, GM
Park-Holohan, SJ
Cook, GJR
Fogelman, I
Citation: Gm. Blake et al., Quantitative studies of bone with the use of F-18-fluoride and Tc-99m-methylene diphosphonate, SEM NUC MED, 31(1), 2001, pp. 28-49
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, The role of positron emission tomography in skeletal disease, SEM NUC MED, 31(1), 2001, pp. 50-61
Authors:
Blake, GM
Fogelman, I
Citation: Gm. Blake et I. Fogelman, Bone densitometry and the diagnosis of osteoporosis, SEM NUC MED, 31(1), 2001, pp. 69-81
Authors:
Blake, GM
Preston, NG
Patel, R
Herd, RJM
Fogelman, I
Citation: Gm. Blake et al., Monitoring skeletal response to treatment: Which site to measure in the femur?, J CLIN DENS, 3(2), 2000, pp. 149-155
Authors:
Rea, JA
Li, J
Blake, GM
Steiger, P
Genant, HK
Fogelman, I
Citation: Ja. Rea et al., Visual assessment of vertebral deformity by X-ray absorptiometry: A highlypredictive method to exclude vertebral deformity, OSTEOPOR IN, 11(8), 2000, pp. 660-668
Authors:
Crabtree, N
Wright, J
Walgrove, A
Rea, J
Hanratty, L
Lunt, M
Fogelman, I
Palmer, R
Vickers, M
Compston, JE
Reeve, J
Citation: N. Crabtree et al., Vertebral morphometry: Repeat scan precision using the lunar Expert-XL andthe hologic 4500A. A study for the 'WISDOM' RCT of hormone replacement therapy, OSTEOPOR IN, 11(6), 2000, pp. 537-543
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Does quantitative ultrasound imaging enhance precision and discrimination?, OSTEOPOR IN, 11(5), 2000, pp. 425-433
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound?, OSTEOPOR IN, 11(4), 2000, pp. 321-330